Invesco NASDAQ Biotechnology ETF
IBBQ
7 hedge funds and large institutions have $63.5M invested in Invesco NASDAQ Biotechnology ETF in 2021 Q2 according to their latest regulatory filings, with 7 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.
0.53% more ownership
Funds ownership: 0% → 0.53% (+0.53%)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Bank of America
Charlotte,
North Carolina
|
+$10.2M |
| 2 |
Citigroup
New York
|
+$10.2M |
| 3 |
CS
Credit Suisse
Zurich,
Switzerland
|
+$10.2M |
| 4 |
Morgan Stanley
New York
|
+$10.2M |
| 5 |
JP Morgan Chase
New York
|
+$10.2M |
Top Sellers
IBBQ Hedge Fund Activity: Q2 2021 in Review
7 of the 5,767 institutional investors tracked by Wall St. Rank reported a position in Invesco NASDAQ Biotechnology ETF (IBBQ) for Q2 2021, worth a combined $63.5M.
Buyers outnumbered sellers: 7 funds opened new IBBQ positions and 0 closed out — a net gain of 7 holders — while 0 added to existing stakes and 0 trimmed.
The largest buyer was Bank of America, opening a new position worth an estimated $10.2M.
- 7 institutional investors held Invesco NASDAQ Biotechnology ETF (IBBQ) as of Q2 2021, up from 0 in Q1 2021.
- Funds reported $63.5M of Invesco NASDAQ Biotechnology ETF stock for Q2 2021.
- 7 funds opened new Invesco NASDAQ Biotechnology ETF positions in Q2 2021 and 0 closed out, a net change of +7 holders.
- The largest Invesco NASDAQ Biotechnology ETF buyer in Q2 2021 was Bank of America, an estimated $10.2M added.
Based on aggregated 13F filings for Q2 2021.